津药药业股份有限公司第九届董事会第二十二次会议决议公告

Core Viewpoint - The board of directors of Tianyao Pharmaceutical Co., Ltd. held its 22nd meeting of the 9th session on November 28, 2025, to approve the performance assessment results and salary determination for senior management for the year 2024 [1][4]. Group 1 - The meeting was conducted via telecommunication and was attended by all 9 directors, meeting the requirements of the Company Law and the company's articles of association [1]. - The performance assessment results for senior management in 2024 were reviewed and approved, with related directors abstaining from the vote [1]. - The voting results showed 6 votes in favor, 0 against, and 0 abstentions [2].